2025-04-18 - Analysis Report
## Eli Lilly and Co. (LLY) Stock Analysis Report

**0. Key Figures Overview:**

LLY exhibits significantly higher cumulative returns than the S&P 500 (VOO) over the analyzed period.  Recent price movements show a strong upward trend, with the price exceeding both short-term and long-term moving averages.  Financial indicators suggest a generally healthy financial position, though volatility should be considered.


**1. Performance Comparison:**

Eli Lilly and Co. (LLY) is a leading pharmaceutical company.

* **LLY Cumulative Return:** 312.35%
* **VOO (S&P 500) Cumulative Return:** 76.18%
* **Return Difference:** 236.2%
* **Relative Divergence:** 72.0% (This indicates LLY's performance is in the upper 72nd percentile of its historical performance relative to the S&P 500, not necessarily that it outperformed by 72%).

The table below shows the Compound Annual Growth Rate (CAGR), Maximum Drawdown (MDD), Alpha, Beta, and Market Capitalization (Cap) for LLY over various periods.  Note that Alpha represents excess return relative to the benchmark.

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 14.0% | 55.9% | -19.0% | 0.1 | 67.7 |
| 2016-2018  | 42.0% | 58.6% | 21.0% | 0.1 | 95.1 |
| 2017-2019  | 55.0% | 58.6% | 21.0% | 1.4 | 110.4 |
| 2018-2020  | 57.0% | 58.6% | 27.0% | 0.7 | 144.7 |
| 2019-2021  | 116.0% | 60.5% | 55.0% | 0.4 | 240.3 |
| 2020-2022  | 111.0% | 64.9% | 102.0% | 0.3 | 322.6 |
| 2021-2023  | 152.0% | 64.9% | 132.0% | 0.3 | 519.2 |
| 2022-2024  | 171.0% | 72.1% | 150.0% | 0.3 | 692.0 |
| 2023-2025  | 144.0% | 76.8% | 130.0% | 0.2 | 754.3 |


LLY shows consistently high CAGR in recent years,  significantly outperforming the market (indicated by high Alpha values).  However, the MDD also increases over time, indicating higher risk.  The Beta values suggest varying levels of market sensitivity across different periods.

**2. Recent Price Movement:**

* **Closing Price:** $839.96
* **Previous Close:** $734.90
* **Daily Change:** $104.06 (14.3% increase - indicating a significant price jump)
* **5-Day Moving Average:** $763.76
* **20-Day Moving Average:** $787.29
* **60-Day Moving Average:** $830.71

The price is currently above all three moving averages, suggesting an upward trend.  The large daily change indicates significant recent volatility.

**3. Technical Indicators:**

* **Market Risk Indicator (MRI):** 0.4223 (Medium Risk)
* **RSI:** 52.44 (Slightly above neutral; not overbought)
* **PPO:** 0.5654 (Positive; suggesting bullish momentum)
* **20-Day Relative Divergence Change:** +4.2% (Short-term upward trend)
* **Expected Return (vs. S&P 500 over 2+ years):** 77.8%

The technical indicators show a generally positive outlook, but the MRI suggests some caution due to moderate risk.  The large price change warrants further investigation into the underlying cause.

**4. Recent Earnings Analysis:**

| Date       | EPS   | Revenue      |
|------------|-------|---------------|
| 2024-10-30 | $1.08 | $11.44 B      |
| 2024-08-08 | $3.29 | $11.30 B      |
| 2024-04-30 | $2.49 | $8.77 B       |
| 2023-11-02 | -$0.06 | $9.50 B       |
| 2024-10-30 | -$0.06 | $9.50 B       |


There's significant variability in EPS, with some quarters showing strong profitability and others showing losses.  Revenue is generally consistent, but further analysis is needed to determine the cause of the EPS fluctuation.  The repeated entry for 2024-10-30 suggests a potential data entry error.

**5. Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue    | Profit Margin |
|---------|-------------|---------------|
| 2024-12-31 | $13.53B    | 82.24%        |
| 2024-09-30 | $11.44B    | 81.02%        |
| 2024-06-30 | $11.30B    | 80.80%        |
| 2024-03-31 | $8.77B     | 80.91%        |
| 2023-12-31 | $9.35B     | 80.88%        |

**Capital and Profitability:**

| Quarter | Equity     | ROE           |
|---------|-------------|---------------|
| 2024-12-31 | $14.19B    | 31.07%        |
| 2024-09-30 | $14.24B    | 6.81%         |
| 2024-06-30 | $13.56B    | 21.88%        |
| 2024-03-31 | $12.81B    | 17.51%        |
| 2023-12-31 | $10.77B    | 20.33%        |


Revenue shows a strong upward trend, and profit margins are consistently high.  ROE is variable, suggesting potential external factors influencing profitability.


**6. Overall Analysis:**

LLY has demonstrated exceptional returns compared to the S&P 500, exhibiting high growth and significant alpha. Recent price action indicates strong upward momentum, supported by positive technical indicators. However, considerable volatility is present, and the inconsistent EPS data requires further investigation.  The high profit margins and generally strong revenue growth signal a healthy financial position.  Before making any investment decisions, thorough due diligence is crucial, considering both the potential for high returns and the inherent risks involved in this volatile stock.  Further research into the reasons behind the fluctuating EPS and the recent significant price jump is strongly recommended.
